• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAK2在丝氨酸523处的磷酸化:一种受生长激素和表皮生长因子刺激的JAK2负调节因子。

Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.

作者信息

Mazurkiewicz-Munoz Anna M, Argetsinger Lawrence S, Kouadio Jean-Louis K, Stensballe Allan, Jensen Ole N, Cline Joel M, Carter-Su Christin

机构信息

Graduate Program in Cellular and Molecular Biology, The University of Michigan Medical School, Ann Arbor, MI 48109-0622, USA.

出版信息

Mol Cell Biol. 2006 Jun;26(11):4052-62. doi: 10.1128/MCB.01591-05.

DOI:10.1128/MCB.01591-05
PMID:16705159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1489095/
Abstract

The tyrosine kinase JAK2 is a key signaling protein for at least 20 receptors in the cytokine/hematopoietin receptor superfamily and is a component of signaling for multiple receptor tyrosine kinases and several G-protein-coupled receptors. In this study, phosphopeptide affinity enrichment and mass spectrometry identified serine 523 (Ser523) in JAK2 as a site of phosphorylation. A phosphoserine 523 antibody revealed that Ser523 is rapidly but transiently phosphorylated in response to growth hormone (GH). MEK1 inhibitor UO126 suppresses GH-dependent phosphorylation of Ser523, suggesting that extracellular signal-regulated kinases (ERKs) 1 and/or 2 or another kinase downstream of MEK1 phosphorylate Ser523 in response to GH. Other ERK activators, phorbol 12-myristate 13-acetate and epidermal growth factor, also stimulate phosphorylation of Ser523. When Ser523 in JAK2 was mutated, JAK2 kinase activity as well as GH-dependent tyrosyl phosphorylation of JAK2 and Stat5 was enhanced, suggesting that phosphorylation of Ser523 inhibits JAK2 kinase activity. We hypothesize that phosphorylation of Ser523 in JAK2 by ERKs 1 and/or 2 or other as-yet-unidentified kinases acts in a negative feedback manner to dampen activation of JAK2 in response to GH and provides a mechanism by which prior exposure to environmental factors that regulate Ser523 phosphorylation might modulate the cell's response to GH.

摘要

酪氨酸激酶JAK2是细胞因子/造血因子受体超家族中至少20种受体的关键信号蛋白,并且是多种受体酪氨酸激酶和几种G蛋白偶联受体信号传导的组成部分。在本研究中,磷酸肽亲和富集和质谱分析确定JAK2中的丝氨酸523(Ser523)为磷酸化位点。一种磷酸化丝氨酸523抗体显示,Ser523在生长激素(GH)刺激下迅速但短暂地被磷酸化。MEK1抑制剂UO126可抑制GH依赖的Ser523磷酸化,这表明细胞外信号调节激酶(ERK)1和/或2或MEK1下游的另一种激酶可响应GH使Ser523磷酸化。其他ERK激活剂,佛波酯12-肉豆蔻酸酯13-乙酸酯和表皮生长因子,也能刺激Ser523的磷酸化。当JAK2中的Ser523发生突变时,JAK2激酶活性以及JAK2和Stat5的GH依赖型酪氨酸磷酸化增强,这表明Ser523的磷酸化会抑制JAK2激酶活性。我们推测,ERK1和/或2或其他尚未确定的激酶使JAK2中的Ser523磷酸化,以负反馈方式抑制JAK2对GH的激活,并提供了一种机制,通过该机制,先前暴露于调节Ser523磷酸化的环境因素可能会调节细胞对GH的反应。

相似文献

1
Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor.JAK2在丝氨酸523处的磷酸化:一种受生长激素和表皮生长因子刺激的JAK2负调节因子。
Mol Cell Biol. 2006 Jun;26(11):4052-62. doi: 10.1128/MCB.01591-05.
2
Phosphorylation of Jak2 on Ser(523) inhibits Jak2-dependent leptin receptor signaling.Jak2蛋白在丝氨酸523位点的磷酸化抑制Jak2依赖的瘦素受体信号传导。
Mol Cell Biol. 2006 Jun;26(11):4063-73. doi: 10.1128/MCB.01589-05.
3
Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.生长激素诱导3T3-F442A细胞中表皮生长因子(EGF)受体的磷酸化。对EGF诱导的转运和信号传导的调节。
J Biol Chem. 2003 May 23;278(21):18902-13. doi: 10.1074/jbc.M300939200. Epub 2003 Mar 14.
4
Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.生长激素诱导的Stat5A和Stat5B的酪氨酰磷酸化及脱氧核糖核酸结合活性
Endocrinology. 1997 Aug;138(8):3426-34. doi: 10.1210/endo.138.8.5332.
5
Termination of growth hormone pulse-induced STAT5b signaling.生长激素脉冲诱导的STAT5b信号传导的终止。
Mol Endocrinol. 1999 Jan;13(1):38-56. doi: 10.1210/mend.13.1.0235.
6
Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.生长激素刺激正常大鼠体内肝脏和骨骼肌中JAK2和STAT5的酪氨酸磷酸化,但不刺激胰岛素受体底物-1或SHC蛋白的酪氨酸磷酸化。
Endocrinology. 1996 Jul;137(7):2880-6. doi: 10.1210/endo.137.7.8770909.
7
Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.鉴定SH2-bbeta为酪氨酸激酶Janus激酶2的一种强效细胞质激活剂。
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7172-7. doi: 10.1073/pnas.96.13.7172.
8
Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.生长激素诱导的Janus激酶2(Jak 2)/信号转导子和转录激活子5(Stat5)信号通路的脱敏需要蛋白质合成和磷脂酶C。
Endocrinology. 1998 Apr;139(4):1815-24. doi: 10.1210/endo.139.4.5931.
9
Epidermal growth factor receptor participates in growth hormone signaling pathway in cardiac myocytes of neonatal rat.表皮生长因子受体参与新生大鼠心肌细胞的生长激素信号通路。
Chin Med J (Engl). 1999 Jun;112(6):546-9.
10
Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.生长激素诱导的Janus激酶2/信号转导子和转录激活子5信号通路的下调需要完整的肌动蛋白细胞骨架。
Exp Cell Res. 2004 Mar 10;294(1):269-80. doi: 10.1016/j.yexcr.2003.11.017.

引用本文的文献

1
2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity.2022 年坎农讲座:向信号转导致敬:生长激素通路如何揭示身高、恶性肿瘤和肥胖的奥秘。
Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E425-E437. doi: 10.1152/ajpendo.00265.2023. Epub 2023 Sep 6.
2
JAK2 in Myeloproliferative Neoplasms: Still a Protagonist.JAK2在骨髓增殖性肿瘤中的作用:依然是主角。
Pharmaceuticals (Basel). 2022 Jan 28;15(2):160. doi: 10.3390/ph15020160.
3
Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms.JAK2V617F 体细胞突变导致骨髓增殖性肿瘤不同表型的潜在机制研究进展。
Int J Mol Sci. 2022 Jan 18;23(3):1013. doi: 10.3390/ijms23031013.
4
MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression.MEK抑制通过主要组织相容性复合体I类(MHC-I)表达激活信号转导和转录激活因子(STAT)信号,以增加乳腺癌免疫原性。
Cancer Drug Resist. 2020;3(3):603-612. doi: 10.20517/cdr.2019.109. Epub 2020 Apr 25.
5
JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs.JAK2S523L,一种在JAK2V617F-骨髓增殖性肿瘤关键自调控残基上的新型功能获得性突变。
Blood Adv. 2020 Sep 22;4(18):4554-4559. doi: 10.1182/bloodadvances.2019001283.
6
Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR.磷酸化蛋白质组分析揭示雌激素-ER 途径通过 DEPTOR 调节 mTOR 活性。
Mol Cell Proteomics. 2019 Aug;18(8):1607-1618. doi: 10.1074/mcp.RA119.001506. Epub 2019 Jun 12.
7
Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase.JAK2酪氨酸激酶调控的机制性见解
Front Endocrinol (Lausanne). 2018 Jan 5;8:361. doi: 10.3389/fendo.2017.00361. eCollection 2017.
8
Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.白细胞介素-2受体β苏氨酸-450磷酸化是受体复合物稳定性和信号分子激活的正调控因子。
J Biol Chem. 2015 Aug 21;290(34):20972-20983. doi: 10.1074/jbc.M115.660654. Epub 2015 Jul 7.
9
Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.骨髓增殖性肿瘤中JAK2调控的分子见解
Blood. 2015 May 28;125(22):3388-92. doi: 10.1182/blood-2015-01-621110. Epub 2015 Mar 30.
10
The molecular regulation of Janus kinase (JAK) activation.Janus激酶(JAK)激活的分子调控
Biochem J. 2014 Aug 15;462(1):1-13. doi: 10.1042/BJ20140712.

本文引用的文献

1
Phosphorylation of Jak2 on Ser(523) inhibits Jak2-dependent leptin receptor signaling.Jak2蛋白在丝氨酸523位点的磷酸化抑制Jak2依赖的瘦素受体信号传导。
Mol Cell Biol. 2006 Jun;26(11):4063-73. doi: 10.1128/MCB.01589-05.
2
A gain-of-function mutation of JAK2 in myeloproliferative disorders.骨髓增殖性疾病中JAK2的功能获得性突变。
N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113.
3
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.真性红细胞增多症、原发性血小板增多症和伴有骨髓纤维化的骨髓化生中酪氨酸激酶JAK2的激活突变。
Cancer Cell. 2005 Apr;7(4):387-97. doi: 10.1016/j.ccr.2005.03.023.
4
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.一种导致持续性信号传导的独特克隆性JAK2突变会引发真性红细胞增多症。
Nature. 2005 Apr 28;434(7037):1144-8. doi: 10.1038/nature03546.
5
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.人类骨髓增殖性疾病中酪氨酸激酶JAK2的获得性突变。
Lancet. 2005;365(9464):1054-61. doi: 10.1016/S0140-6736(05)71142-9.
6
The Janus kinases (Jaks).酪氨酸激酶(Jaks)。
Genome Biol. 2004;5(12):253. doi: 10.1186/gb-2004-5-12-253. Epub 2004 Nov 30.
7
Determination of the transphosphorylation sites of Jak2 kinase.Jak2激酶转磷酸化位点的测定
Biochem Biophys Res Commun. 2004 Dec 10;325(2):586-94. doi: 10.1016/j.bbrc.2004.10.071.
8
Phosphorylation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-2 reduces receptor signaling and interaction with the Na(+)/H(+) exchanger regulatory factor.G蛋白偶联受体激酶-2介导的血小板衍生生长因子受体-β磷酸化可降低受体信号传导以及与钠/氢交换调节因子的相互作用。
J Biol Chem. 2004 Oct 1;279(40):41775-82. doi: 10.1074/jbc.M403274200. Epub 2004 Jul 22.
9
Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.14-3-3蛋白与磷蛋白之间的动态相互作用调节着多种细胞过程。
Biochem J. 2004 Jul 15;381(Pt 2):329-42. doi: 10.1042/BJ20031332.
10
Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling.
Mol Cell Biol. 2004 Jun;24(11):4968-78. doi: 10.1128/MCB.24.11.4968-4978.2004.